Antiarrhythmic drugs: from mechanisms to clinical practice.
Roden
D M
DM
Vanderbilt University School of Medicine, Nashville, Tennessee 37232-6602, USA. Dan.Roden@MCMail.Vanderbilt.edu
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000378:metabolism / Q000401:mortality; D002121:Calcium Channel Blockers / Q000009:adverse effects / Q000627:therapeutic use; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D006801:Humans; D007473:Ion Channels / Q000187:drug effects*; D018579:Patient Selection; D015222:Sodium Channels / Q000187:drug effects; D016171:Torsades de Pointes / Q000139:chemically induced
D000319:Adrenergic beta-Antagonists; D000889:Anti-Arrhythmia Agents; D002121:Calcium Channel Blockers; D007473:Ion Channels; D015222:Sodium Channels